Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CCR1 | P32246 | 1/20 | 0.33 |
| ▸ | CCR8 | P51685 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | TOP1 | P11387 | 5/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 4/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.32 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.32 |
| ▸ | MET | P08581 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | HTR5A | P47898 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17229484 | 0.90 | CCR1 (0.36) | KMT2ACCR1CCR8NPC1POLB | |
| SCHEMBL17229480 | 0.89 | CCR1 (0.36) | KMT2ACCR1CCR8NPC1POLB | |
| SCHEMBL17229481 | 0.88 | KMT2A (0.39) | KMT2ANPC1RAB9ADHODHAKR1C3 | |
| SCHEMBL17229482 | 0.85 | LMNA (0.33) | NPC1POLBRAB9ATOP1HSP90AA1 | |
| SCHEMBL17229478 | 0.85 | LMNA (0.33) | KMT2ANPC1POLBRAB9ATOP1 | |
| SCHEMBL17229479 | 0.83 | ADORA2A (0.37) | KMT2ACCR1CCR8NPC1POLB | |
| SCHEMBL17229516 | 0.83 | KDM4E (0.33) | CCR1CCR8TOP1DHODHLMNA | |
| SCHEMBL17229498 | 0.80 | CCR1 (0.35) | KMT2ACCR1CCR8NPC1POLB | |
| SCHEMBL17229520 | 0.80 | KDM4E (0.31) | CCR1CCR8HSP90AA1LMNA | |
| SCHEMBL17229518 | 0.78 | RAB9A (0.35) | NPC1RAB9AMET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150318490-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-11-05 | — | — | US | disclosed |
| US-20150318490-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150318490-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME | CRY1, CRY2, CCNA1 | KMT2A 2505/4885CCR1 258/4885CCR8 1347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.